FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 1944552 · Received January 3, 2011

Report

Report Number
2124215-2010-19719
Event Type
Malfunction
Date Received
January 3, 2011
Date of Event
August 12, 2010
Report Date
October 6, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE AVAILABLE INFORMATION SUGGESTS THAT THIS DEVICE REMAINS IN-SERVICE. THE EVENT WILL BE REOPENED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS PATIENT RECEIVED SHOCK THERAPY. THE CLINIC RN ASKED WHY THE EPISODE WAS NOT DISPLAYED IN LATITUDE. TECHNICAL SERVICES EXPLAINED THAT DEVICE INTERROGATION HAD NOT BEEN PERFORMED POST-SHOCK. BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE PATIENT RECEIVED INAPPROPRIATE SHOCKS DUE FOR SINUS TACHYCARDIA (ST). TECHNICAL SERVICES EXPLAINED THAT DETECTION ENHANCEMENTS ARE NOT AVAILABLE IF THE ARRHYTHMIA ACCELERATES FROM A VT-1 (MONITOR ONLY) ZONE TO A VT ZONE. TECHNICAL SERVICES DISCUSSED PROGRAMMING OPTIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 65 YR (B)(4)| (B)(4)| (B)(4)| (B)(4)